AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Merlani, G Fox, M Oehen, HP Cathomas, G Renner, EL Fattinger, K Schneemann, M Kullak-Ublick, GA
Citation: G. Merlani et al., Fatal hepatotoxicity secondary to nimesulide, EUR J CL PH, 57(4), 2001, pp. 321-326

Authors: Kullak-Ublick, GA Ismair, MG Stieger, B Landmann, L Huber, R Pizzagalli, F Fattinger, K Meier, PJ Hagenbuch, B
Citation: Ga. Kullak-ublick et al., Organic anion-transporting potypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver, GASTROENTY, 120(2), 2001, pp. 525-533

Authors: Rentsch, KM Kullak-Ublick, GA Reichel, C Meier, PJ Fattinger, K
Citation: Km. Rentsch et al., Arterial and venous pharmacokinetics of intravenous heroin in subjects whoare addicted to narcotics, CLIN PHARM, 70(3), 2001, pp. 237-246

Authors: Fattinger, K Funk, C Pantze, M Weber, C Reichen, J Stieger, B Meier, PJ
Citation: K. Fattinger et al., The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions, CLIN PHARM, 69(4), 2001, pp. 223-231

Authors: Fattinger, K Roos, M Vergeres, P Holenstein, C Kind, B Masche, U Stocker, DN Braunschweig, S Kullak-Ublick, GA Galeazzi, RL Follath, F Gasser, T Meier, PJ
Citation: K. Fattinger et al., Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine, BR J CL PH, 49(2), 2000, pp. 158-167

Authors: Fattinger, K Cattori, V Hagenbuch, B Meier, PJ Stieger, B
Citation: K. Fattinger et al., Rifamycin SV and rifampicin exhibit differential inhibition of the hepaticrat organic anion transporting polypeptides, Oatp1 and Oatp2, HEPATOLOGY, 32(1), 2000, pp. 82-86

Authors: Fattinger, K Benowitz, NL Jones, RT Verotta, D
Citation: K. Fattinger et al., Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine, EUR J CL PH, 56(4), 2000, pp. 305-310

Authors: Durr, D Stieger, B Kullak-Ublick, GA Rentsch, KM Steinert, HC Meier, PJ Fattinger, K
Citation: D. Durr et al., St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4, CLIN PHARM, 68(6), 2000, pp. 598-604
Risultati: 1-8 |